Hap (Robert) Sneddon FCSI

Market sentiment is crappy, but you want that to invest. People are really fearful. Will tariffs be repealed? Now, we're in a pause before the rally resumes. Corporate earnings aren't too bad. Sentiment is negative. So, a good time to start investing. Technology, energy and small caps look good. Also, biotechs and financials. International markets are perking up, like Europe.

Is up 56% this year. It went sideways for the first quarter of 2025, then broke out. He likes energy. There will be volatility here, such as mid-October. Don't wait for a dip. Given the trend, buy now.

It's been basing since last September. Pays a decent dividend. As long as it holds $60, this won't revisit $49. Should be a core holding you hold for a long time.

The first thing he sees in the chart is a downtrend. Biotech is lagging the benchmarks. If it breaks $42, the downtrend will continue. Look for a higher low before stepping in.

This bottomed with the market in April and has risen with the mark since then. He wants to see this break $26; if so, it will take off. Be patient. Most money is made by sitting on your hands.

You want to see it break the current $252; if so, it will attract new buyers. The chart the past 2 months is an inverted head and shoulders. The chart based in Q1, then broke out after early April's lows. Micron looks good.

Not a bad chart, but is a volatile stock. If you're into Canadian tech, you have to own this. Is very global, but tied to consumption. The consumer has not been the most robust. Hold the right proportion in your portfolio.

Recent lows were around $250 and $300, and you want the chart to hold above those level. Watch if this breaks below $300; if so, be ready to exit. They had a rough spring and detached from the wider market. 

Based in France. They power AI. But is pretty volatile. He made profits, then exited.

It's back to April's lows. Is a quality company. They have a wide moat. Can hold long term, but the sector is not great now. Is up 135% over the past 5 years. But it would fall to $850--still wouldn't sell.

He entered low and paid a high dividend. Would still but it today.

He sold it. It frustrated the crap out of him. Like Knight Therapeutics, it's a Canadian health stock that seemed to have a good story and decent earnings. But it didn't catch fire. The chart shows it bottoms around $3.75. At best, it will hold that level and march up. Canadian healthcare stocks need a lot of patience.

It's back to its February low of $17, which offers good risk/reward and a place to hang your hat on. That's the best you can say. Though, if you bought at $26, it's painful to see such a sharp drop. Is down 10% this year, not terrible. So, now is an opportunity, but if it breaks $17, then exit.

The sell-off in October and November was overdone. He's really interested in it. He has to study its fundamentals more, though.

He prefers gold. They call silver the "widowmaker". It's up nearly 100% this year, a big move. Silver has commercial application in AI and aerospace. The trend is up. Gold and silver enter seasonal strength now. To follow gold, watch the biggest silver companies like First Majestic.